BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1983220)

  • 1. [Multiple endocrine type 2 neoplasia in 3 families].
    Palchik M; Sánchez A; Góméz J; Rodríguez Pécora A
    Medicina (B Aires); 1990; 50(2):117-23. PubMed ID: 1983220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of screening for medullary thyroid carcinoma in families of patients with MEN 2.
    Frilling A; Goretzki PE; Bastian L; Roeher HD
    Henry Ford Hosp Med J; 1989; 37(3-4):122-3. PubMed ID: 2576942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early detection of medullary thyroid carcinoma in multiple endocrine neoplasia type II].
    Ezabella MC; Hayashida CY; Bisi H; Leite MO; Borelli A; Abelin NM; Cordeiro AC; Camargo RY; Toledo SP
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(3):105-9. PubMed ID: 1983764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
    Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
    Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
    Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
    Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple endocrine neoplasia II A syndrome: relationship between age of the patient, levels of basal calcitonin and size of the thyroid tumor].
    Parrilla P; Candel MF; Ponce JL; Tebar J; Albarracin A; Rodriguez JM
    Minerva Chir; 1992 May; 47(9):831-8. PubMed ID: 1352395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary medullary thyroid carcinoma.
    Vasen HF; Vermey A
    Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A].
    Pati M; Sperti P; Magiar AV; Bonifacio V
    Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sporadic and hereditary forms of medullary thyroid carcinoma.
    Rosenberg-Bourgin M; Gardet P; de Sahb R; Schlumberger M; Caillou B; Guilloud-Bataille M; Travagli JP; Feingold N; Parmentier C
    Henry Ford Hosp Med J; 1989; 37(3-4):141-3. PubMed ID: 2576948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of medullary thyroid carcinoma in a thirteen-year-old girl with MEN 2B.
    Tisell LE; Jansson S
    Henry Ford Hosp Med J; 1989; 37(3-4):157-9. PubMed ID: 2576953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid].
    Rafecas A; Ribas Y; Villabona C; Viladrich M; Figueras J; Fabregat J; Torras J; Gómez JM; Jaurrieta E
    Med Clin (Barc); 1998 Nov; 111(16):619-22. PubMed ID: 9881336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a screening program for multiple endocrine neoplasia type II.
    Fletcher DR; Gamvros O; MacFarlane A; Ward-McQuaid JN; Lynn J
    Surg Gynecol Obstet; 1984 Aug; 159(2):119-26. PubMed ID: 6147022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of children with medullary thyroid carcinoma.
    Libroia A; Muratori F; Verga U; Di Sacco G; Grattieri A; Gelli D
    Henry Ford Hosp Med J; 1992; 40(3-4):281-3. PubMed ID: 1362424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia type 2B: eighteen-year follow-up of a four-generation family.
    Sizemore GW; Carney JA; Gharib H; Capen CC
    Henry Ford Hosp Med J; 1992; 40(3-4):236-44. PubMed ID: 1362413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with a provocative test of calcitonin release as a prospective screening for preclinical medullary thyroid carcinoma in MEN type 2A family members.
    van Lathem JJ; Vermaak WJ; Kuyl JM; Mollentze W; Jansen S; Wolmarans L; Pelser H; Barry R; Kruger AJ; Wolfaardt M
    J Clin Lab Anal; 1992; 6(6):384-90. PubMed ID: 1359042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.